Literature DB >> 20611003

Airway pressure release ventilation reduces the increase in bronchoalveolar lavage fluid high-mobility group box-1 levels and lung water in experimental acute respiratory distress syndrome induced by lung lavage.

Yoshiyasu Matsuzawa1, Koichi Nakazawa, Akio Yamamura, Takumi Akashi, Keisuke Kitagaki, Yoshinobu Eishi, Koshi Makita.   

Abstract

BACKGROUND AND
OBJECTIVE: Airway pressure release ventilation (APRV) may provide better alveolar recruitment at a lower peak airway pressure than conventional mechanical ventilation (CMV) and, therefore, decrease the risk of barotrauma in patients with acute lung injury and acute respiratory distress syndrome. The present study compared the effects of APRV with low tidal volume ventilation (LTV) and CMV on the ongoing response in lung injury induced by whole lung lavage.
METHODS: Lung injury was induced by whole lung lavage. Twenty-one Japanese white rabbits were randomized to receive CMV (tidal volume 10 ml kg, positive end-expiratory pressure 3 cmH2O), LTV (tidal volume 6 ml kg, positive end-expiratory pressure 10 cmH2O), or APRV (Phigh 20 cmH2O, Plow 5 cmH2O). After 4 h of treatment, the lungs and heart were excised en bloc. The left lung was lavaged, and high-mobility group box-1 (HMGB1) levels were measured in the lavage. The right lung was analysed histologically and its wet-to-dry weight ratio was calculated.
RESULTS: PaO2 was decreased after the induction of lung injury, but the values were significantly higher in the APRV and LTV groups after treatment than in the CMV group. Serum HMGB1 levels did not change before and after lung injury; however, bronchoalveolar lavage fluid HMGB1 levels were significantly increased at the end of the experiment (266.8 +/- 47.9 in the CMV group, 137.4 +/- 23.4 in the LTV group, and 91.2 +/- 5.4 ng ml in the APRV group). The bronchoalveolar lavage fluid HMGB1 levels after experiment were significantly lower in the APRV group than in the CMV and LTV groups (P < 0.0001 and P = 0.0391, respectively). Wet-to-dry weight ratios were also lowest in the APRV group.
CONCLUSION: APRV reduces bronchoalveolar lavage fluid HMGB1 levels and lung water and it preserves oxygenation and systemic blood pressure in experimental acute respiratory distress syndrome. The results suggest that APRV could be as protective for acute respiratory distress syndrome as LTV with positive end-expiratory pressure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20611003     DOI: 10.1097/EJA.0b013e328333c2b0

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  8 in total

1.  The effect of APRV ventilation on ICP and cerebral hemodynamics.

Authors:  Paul E Marik; Alisha Young; Steve Sibole; Alex Levitov
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 2.  Pulmonary Interstitial Matrix and Lung Fluid Balance From Normal to the Acutely Injured Lung.

Authors:  Egidio Beretta; Francesco Romanò; Giulio Sancini; James B Grotberg; Gary F Nieman; Giuseppe Miserocchi
Journal:  Front Physiol       Date:  2021-12-20       Impact factor: 4.566

3.  Inhaled aerosolized insulin ameliorates hyperglycemia-induced inflammatory responses in the lungs in an experimental model of acute lung injury.

Authors:  Wei Fan; Koichi Nakazawa; Shinya Abe; Miori Inoue; Masanobu Kitagawa; Noriyuki Nagahara; Koshi Makita
Journal:  Crit Care       Date:  2013-04-28       Impact factor: 9.097

4.  Experiences Using Airway Pressure Release Ventilation for Pneumonia with Severe Hypercapnia or Postoperative Pulmonary Edema.

Authors:  Kyung Sook Hong; Young-Joo Lee
Journal:  Korean J Crit Care Med       Date:  2017-02-28

5.  Airway pressure release ventilation versus low tidal volume ventilation for patients with acute respiratory distress syndrome/acute lung injury: a meta-analysis of randomized clinical trials.

Authors:  Xi Zhong; Qin Wu; Hao Yang; Wei Dong; Bo Wang; Zhongwei Zhang; Guopeng Liang
Journal:  Ann Transl Med       Date:  2020-12

Review 6.  The 30-year evolution of airway pressure release ventilation (APRV).

Authors:  Sumeet V Jain; Michaela Kollisch-Singule; Benjamin Sadowitz; Luke Dombert; Josh Satalin; Penny Andrews; Louis A Gatto; Gary F Nieman; Nader M Habashi
Journal:  Intensive Care Med Exp       Date:  2016-05-20

7.  Experimental study of airway pressure release ventilation in the treatment of acute respiratory distress syndrome.

Authors:  Guan-Jie Han; Jia-Qiong Li; Cui-Gai Pan; Jing-Xi Sun; Zai-Xiang Shi; Ji-Yuan Xu; Mao-Qin Li
Journal:  Exp Ther Med       Date:  2017-07-06       Impact factor: 2.447

8.  The safety and efficacy of airway pressure release ventilation in acute respiratory distress syndrome patients: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Xuri Sun; Yuqi Liu; Neng Li; Deyuan You; Yanping Zhao
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.